US HB6019 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 7-2)
Status: Introduced on February 28 2020 - 25% progression, died in committee
Action: 2020-02-28 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 28 2020 - 25% progression, died in committee
Action: 2020-02-28 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
Title
Cure the Coronavirus Act
Sponsors
| Rep. Hakeem Jeffries [D-NY] | Rep. Peter King [R-NY] | Rep. Tony Cardenas [D-CA] | Rep. Jaime Herrera Beutler [R-WA] |
| Rep. David Trone [D-MD] | Rep. Yvette Clarke [D-NY] | Rep. Steve Cohen [D-TN] | Rep. Jahana Hayes [D-CT] |
| Rep. Josh Harder [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-02-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2020-02-28 | House | Introduced in House |
Subjects
Cardiovascular and respiratory health
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Health
Infectious and parasitic diseases
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Health
Infectious and parasitic diseases
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/6019/all-info |
| Text | https://www.congress.gov/116/bills/hr6019/BILLS-116hr6019ih.pdf |
